Pharmacy Podcast Network

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.
Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.
Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that's truly peer-reviewed. The future of podcasting education for Providers is "Evidence-based Podcasting" (TM) and we're building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.
PPN is a division of RxPR, LLC. Copyright 2026
Episodes
Episodes



Thursday Oct 30, 2025
Lies and Lawsuits | Essential: Pharmacy Compounding Podcast APC
Thursday Oct 30, 2025
Thursday Oct 30, 2025
In this edition of Essential, we look at how we’re pushing back against the FDA’s upcoming ban on desiccated thyroid extract, why drugmakers’ latest tactics against compounding pharmacies are backfiring, and we give you a great way to make sure your practice is performing at its best.Then we take a deep dive with attorney and pharmacist Mark Boesen into the lawsuits being filed against compounding pharmacies, what the results have been, and how they might affect more than just pharmacy in the future. Boesen & Snow Law: https://www.boesensnowlaw.com/DTE story (https://a4pc.org/news/ask-your-patients-help-us-protect-dte-access)“FDA’s confusing warning letters” (https://a4pc.org/news/fdas-confusing-warning-letters)“FDA’s green list: Not our problem?” (https://a4pc.org/news/fdas-green-list-not-our-problem)Compounding.com/thyroidBest practices documents (a4pc.org/bestpractices)National Review article on FDA crackdown (https://archive.ph/LYy7t)



Wednesday Oct 29, 2025
NSAIDs: Everything and Then Some | Pain Pod
Wednesday Oct 29, 2025
Wednesday Oct 29, 2025
NSAIDs are everywhere, prescription, OTC, topical, oral, injectable, you name it!In an era of Opioidphobia, are they really a panacea? Heck no, all medications come with baggage.We could spend hours talking about NSAIDs, and not even get to the elephant in the room: Which NSAID for Which Patient? So we’ll go there in this succinct, yet comprehensive rapid review of all things NSAIDs on the Pain Pod!Come one, come all, to the Pain Pod!!!Pain Guy• www.painguy.us



Tuesday Oct 28, 2025
KIDs List Lowdown | Pediatric Pharmacist Review
Tuesday Oct 28, 2025
Tuesday Oct 28, 2025
In this episode of The Pediatric Pharmacist Review, we delve into the 2025 KIDs List—the Pediatric Pharmacy Association's updated guide highlighting key potentially inappropriate medications in pediatric care. This comprehensive list serves as a critical resource for clinicians aiming to enhance medication safety and optimize pharmacotherapy in pediatric populations.Meet the Experts:Dr. Rachel S. Meyers brings a wealth of experience as a Clinical Professor at Rutgers University and a Pediatric Clinical Pharmacist at Cooperman Barnabas Medical Center. Her clinical insights and academic contributions have significantly influenced pediatric pharmacy practice.Dr. David Hoff serves as the Pharmacy Director for Acute Care at Children’s Minnesota and holds the position of Section Editor at JPPT. With over 30 years of experience, he has been instrumental in developing and updating the KIDs List, ensuring it reflects the latest evidence and best practices.Key Discussion Points:The evolution and significance of the KIDs List in pediatric pharmacotherapyStrategies for integrating the KIDs List into clinical practiceThe impact of inappropriate medications on pediatric patient outcomesCollaborative efforts in pediatric medication safetyFurther Reading:For a comprehensive understanding, access the full 2025 KIDs List here: 2025 KIDs List PDF



Monday Oct 27, 2025
The NASP Specialty Pharmacy Expo RECAP Show | Part Three
Monday Oct 27, 2025
Monday Oct 27, 2025
The Pharmacy Podcast Network is back on the show floor at the NASP Annual Expo, live in Denver, CO!Thank you JB Consulting for Sponsoring this episode!On part one of this series we interview:
Jennifer Noonan with Accessia Health
Shaun Jensen with JB Consulting
Kevin Kallmes with Nested Knowledge AI
Lee Pratt with ProChant
Mai Tang with Two Trees Consulting
Nick Calla with Orsini
Reed Kalna with Kaiser Permanente
Richard Brook with Better Worldwide Health
Ryne A. Clark with Keysource
Sheila Arquette, President and CEO of the NASP



Friday Oct 24, 2025
Access, Advocacy & Appreciation: The Heart of Pharmacy in Motion | TWIRx
Friday Oct 24, 2025
Friday Oct 24, 2025
Access, Advocacy & Appreciation: The Heart of Pharmacy in Motion --it's time to #TWIRx on October 24th, 2025, it's FRIDAY!! Up first is TWIRx News:From Pharmacy Times, Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy. https://lnkd.in/e2CwGUt8NEXT from Drug Store News, Pharmacies can close health care gaps for millions while realizing substantial savings for employers A new national study from the Health Action Alliance, commissioned by NACDS, shows pharmacy-based care reduces costs while meeting employee demands for convenient access. https://lnkd.in/eYmrQnHQNEXT from Open PR, New Research Peptide Supplier Plans Pharmacy Collaborations to Support Licensed Wellness Clinic Sector https://lnkd.in/evkgZtn5NEXT Study shows alarming drop in pharmacy access in Massachusetts --reporting from WWLP-22News from Boston https://lnkd.in/egWg6G3rIn this episode of This Week in Pharmacy, host Todd Eury welcomes featured guest Tiara Green, President of Accessia Health, whose mission is to connect patients without insurance to life-saving medication funding.LINK: https://lnkd.in/gV4VjeZn We also check in with Jesse McCullough for Day 24 of the 31-Day #Pharmacist Month Challenge, with a special call to action to support the 40+ shows and incredible hosts creating content for the pharmacy profession through the Pharmacy Podcast Network.LINK: https://lnkd.in/efvZ6Smv Plus, Mike Johnston, CPhT-Adv, CEO of the NPTA - National Pharmacy Technician Association (NPTA), joins us to share insights on Meaningful Recognition and what pharmacy technicians truly want as we celebrate World Pharmacy Technician Day.LINK: https://lnkd.in/gz-Gcxvg 🎧 Empowering the profession, one story at a time.Thank you to Independent Pharmacy Cooperative (IPC) and Sykes & Company, P.A. for always supporting #TWIRx in the Works!!



Wednesday Oct 22, 2025
Live from the FrameworkLTC Innovation Conference (Part 3) | FrameworkFocus™
Wednesday Oct 22, 2025
Wednesday Oct 22, 2025
In the final installment of our three-part series, host Todd Eury wraps up his live coverage from the 2025 FrameworkLTC Innovation Conference. Tune in for more engaging interviews with LTC pharmacy attendees, partner exhibitors, and SoftWriters team members as they reflect on the event’s biggest moments and discuss what’s ahead for the LTC pharmacy community.



Tuesday Oct 21, 2025
The NASP Specialty Pharmacy Expo RECAP Show | Part Two
Tuesday Oct 21, 2025
Tuesday Oct 21, 2025
The Pharmacy Podcast Network is back on the show floor at the NASP Annual Expo, live in Denver, CO!Thank you Accessia for Sponsoring this episode!On part two of this series we interview:
Jennifer Noonan with Accessia Health
Nick Negri with ALTOR
Cecila Byers with Surescripts
Jill Paslier with Specia
Jon Hamrick with Curatio Advisors
Jonathan Orgurchak and Brandon Hardin
Steve Pharmacy Attorney
Tammy Dean with Cold Chain Technologies



Monday Oct 20, 2025
Monday Oct 20, 2025
The NCPA Digest, presented by the National Community Pharmacists Association (NCPA) and Cardinal Health, is a comprehensive analysis quantifying and profiling the state of independent community pharmacy. From benchmarking performance and implementing process improvements to identifying new strategies that have proven successful for their peers, there are many ways independent pharmacies can leverage this annual report.In this episode, NCPA’s Doug Hoey and Lisa Schwartz join Cardinal Health’s Michelle Britt and Rebecca McGrath to discuss the findings from the 2025 NCPA Digest and how independent pharmacists’ collective voices help inform this industry publication. They also share examples of how readers can use the Digest as an advocacy tool in conversations with elected officials and policymakers.



Friday Oct 17, 2025
PRISM Enters the Chat & LTC Insurance in Pharmacy | TWIRx RxRated
Friday Oct 17, 2025
Friday Oct 17, 2025
PRISM Enters the Chat & LTC Insurance in Pharmacy | TWIRx RxRated Version
📅 Release Date: October 17, 2025🎧 Produced by: Pharmacy Podcast Network
🧠 Segment 1: Innovation Spotlight – OvaryIT & the PRISM Platform
Guests:
Mary Kucek, CEO & Founder, OvaryIT
Devin Bustin, MD, Chief Medical Officer, OvaryIT
The future of pharmacy practice management has arrived. Mary Kucek and Dr. Devin Bustin introduce PRISM, the first fully integrated EHR system built exclusively for community pharmacists. PRISM streamlines clinical workflows, ensures compliance, and empowers pharmacists to expand services—from point-of-care testing and chronic disease management to vaccinations and remote patient monitoring. This segment unpacks how PRISM helps protect your license, improve patient outcomes, and grow your business with technology designed by pharmacists, for pharmacists.
💡 Segment 2: Financial Literacy & Long-Term Care Planning with Michael Banner
Guest:
Michael Banner, Founder & Host, 62WhoKnew Podcast
Michael Banner brings decades of expertise across the mortgage, financial, and LTC insurance industries to discuss how pharmacists and healthcare professionals can better educate aging populations about financial security and care planning. Learn why he built 62WhoKnew as the ultimate referral source for retirement preparation and hear insights on integrating long-term care insurance discussions into pharmacy-based clinical care models.
💰 Segment 3: The 8th Annual Pharmacy Profit Summit
Guest:
Lisa Faast, PharmD, CEO, DiversifyRx
Get ready for the Pharmacy Profit Summit 2025—happening March 26–27 in Dallas, TX. Dr. Lisa Faast shares what’s new for the 8th annual event, including innovative strategies to boost profitability, reduce overhead, and future-proof independent pharmacies. Hear what attendees can expect from this year’s sessions, networking, and vendor showcases that make the Summit a can’t-miss event for forward-thinking pharmacy owners.
💬 Segment 4: TWIRx RxRated Roundtable – Trust, Transparency, and Controversy in Healthcare
Hosts:
Robbie Abasi, PharmD
Sam Ilona, PharmD
Xavier Hill, PharmD, BCPS, BCGP
The RatedRx Podcast team joins TWIRx for an unfiltered discussion on trust in healthcare, media narratives, and the controversy shaping public perception of the profession. From patient misinformation to provider burnout, this roundtable doesn’t hold back—bringing authenticity and humor to the realities of modern pharmacy.
🔊 Episode Summary
This week on This Week in Pharmacy, innovation meets impact. From next-generation EHR technology with PRISM to retirement readiness and LTC awareness with Michael Banner, plus a spotlight on profit-driven growth with DiversifyRx’s Lisa Faast—this episode covers the clinical, business, and human sides of pharmacy. We wrap it all up with RatedRx, where pharmacists talk real about the issues shaping trust in healthcare today.



Thursday Oct 16, 2025
The NASP Specialty Pharmacy Expo RECAP Show | Part One
Thursday Oct 16, 2025
Thursday Oct 16, 2025
The Pharmacy Podcast Network is back on the show floor at the NASP Annual Expo, live in Denver, CO!Thank you JB Consulting for Sponsoring this episode!On part one of this series we interview:
Christine Tang Wilson with Lumicera Health Services
Amanda Awe with VLP
Christopher Corsi, CEO, CassianRx
Hayley Burgess with Inovalon
Eric Robertson with DoseSpot
Harry Travis with The Travis Group LLC
Ethan Wynn with Sphinx Strategies
Heidi Polleck with Outcomes



Wednesday Oct 15, 2025
Live from the FrameworkLTC Innovation Conference (Part 2) | FrameworkFocus™
Wednesday Oct 15, 2025
Wednesday Oct 15, 2025
In part two of our exclusive three-part series, host Todd Eury continues the conversation live from the 2025 FrameworkLTC Innovation Conference. Hear from LTC pharmacy professionals, trusted partners, and SoftWriters experts as they share their experiences, key takeaways, and perspectives on the evolving world of long-term care pharmacy.



Tuesday Oct 14, 2025
Tuesday Oct 14, 2025
I had the honor of interviewing a like-hearted soul whom I deeply respect and admire, around the topic of transmuting our grief, rage + fear about the wider big picture of the world. For such a heavy topic, I came out of it inspired to connect deeper with nature, and grateful for the gift of life.Gwyneth Jones guides individuals through the emotional and spiritual journey of confronting the state of our world, drawing upon a diverse toolkit that includes ecotherapy, emotional intelligence, mindfulness, and positive psychology. She is a certified coach and Work that Reconnects facilitator, as well as a writer and podcast host on topics relating to our psychological and spiritual response to collapse, ecopsychology and our connection to the web of life, and effective changemaking.Connect with Gwyneth via:Email: gwynethajones86@gmail.com Website: Gwyneth Jones Coach & ConnectorFB: Gwyneth Jones - Coach & ConnectorIG: @gwynethjones.connectioncoachLinked In: Gwyneth JonesGet the epic “Staying Grounded in Times of Crisis” ebook, available as a free download from her website. And check out our upcoming livestream about herbalism as a form of resilience on September 25th, and our interactive workshop on this topic on October 23rd! We look forward to building community and sharing the tools that our ancestors worked with and are still relevant today.Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com. Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.



Monday Oct 13, 2025
Monday Oct 13, 2025
Independent pharmacy owners face unique challenges. On this episode of Counter Talk™ Podcast, host Jason Callori speaks with Jason Kizer, PharmD, owner of Kizer Pharmacy, about revitalizing your pharmacy's culture. Discover strategies to boost staff morale, empower your team to provide exceptional patient care, and build a trusted healthcare destination. Jason shares his journey of pharmacy ownership and how he fostered a culture shift within his team.



Friday Oct 10, 2025
The Devil Wore a Lab Coat & PBM Reform in Illinois | TWIRx
Friday Oct 10, 2025
Friday Oct 10, 2025
🎙️ Featured Guests:
John Covello – Independent Pharmacy Cooperative (IPC)
Garth Reynolds – Illinois Pharmacists Association (IPhA)
Illinois pharmacy owners, this episode is for you. With the passage of HB 1697, a $70 million lifeline is now available to support independent pharmacies across the state—but the clock is ticking. The October 31st deadline is critical.
Covello and Reynolds break down:
The Critical Access Pharmacy Fund – how it strengthens local pharmacies.
The DECO program – what it means for reimbursement.
Patient Self-Management Programs (PSMP) – driving patient care and outcomes.
The one-minute attestation that unlocks enhanced Medicaid dispensing fees.
If you’re a pharmacy owner in Illinois, this could be the most important 30 minutes you’ll spend this month.
🎶 Special Feature: Mary Kutter
This week, TWIRx also spotlights Mary Kutter, a rising country singer-songwriter from Kentucky. Known for her gritty, truthful storytelling, Kutter’s music explores themes of family, small-town struggles, and the opioid crisis.
With viral songs like “Devil’s Money” and “The Devil Wore a Lab Coat”, plus songwriting credits for artists like Bailey Zimmerman, Kutter’s voice is shaping the soundtrack of rural America. Signed with Reservoir Media, she brings a raw perspective on how music can confront issues like addiction while honoring her Kentucky roots.
💡 Episode Highlights:
The $70M opportunity Illinois pharmacies can’t afford to miss.
How independent pharmacies can secure financial stability through HB 1697.
Why Medicaid fee enhancements could change the game.
Mary Kutter on blending country grit with the reality of the opioid epidemic.
📌 Don’t miss this episode of This Week in Pharmacy. It’s where policy, patient care, and culture intersect.



Friday Oct 10, 2025
Bypass the PBMs for More Pharmacy Profit | PBM Reform
Friday Oct 10, 2025
Friday Oct 10, 2025
The host has been a community pharmacy advocate for 22 years. Always looking for ways to help community pharmacies be more profitable. The guest is an experienced Pharmacist with a demonstrated history of working in the pharmaceutical industry. Skilled in Diabetes, Pharmacy Practice, Community Pharmacy, and Clinical Pharmacology.



Thursday Oct 09, 2025
Hypothyroidism in Long-Term Care: The Pharmacist's Role | YARAL Pharma
Thursday Oct 09, 2025
Thursday Oct 09, 2025
This podcast is sponsored by YARAL Pharma.
In this episode, we are focusing on the management of hypothyroidism -- a treatable, but not curable condition – and will explore unique challenges for patients with hypothyroidism in long-term care – from tolerability and formulation considerations to consistent dosing and patient needs.
Dr. Tamara Ruggles is not affiliated with YARAL Pharma. All views and opinions regarding hypothyroidism are solely her own and are not attributable to YARAL or the Pharmacy Podcast Network.
IMPORTANT SAFETY INFORMATION for levothyroxine sodium capsules
INDICATION AND USAGE
Levothyroxine sodium capsules are L-thyroxine (T4) indicated for adults and pediatric patients 6 years and older with:
Hypothyroidism - As replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism
Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression - As an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well differentiated thyroid cancer
Limitations of Use:
Levothyroxine sodium capsules are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with Levothyroxine sodium capsules may induce hyperthyroidism.
Levothyroxine sodium capsules are not indicated for treatment of transient hypothyroidism during the recovery phase of subacute thyroiditis
WARNING: NOT FOR THE TREATMENT OF OBESITY OR FOR WEIGHT LOSS Thyroid hormones, including levothyroxine sodium capsules, either alone or with other therapeutic agents, should not be used for the treatment of obesity or for weight loss. In euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction. Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for their anorectic effects.
Contraindications
Uncorrected adrenal insufficiency
Warnings and Precautions
Cardiac adverse reactions in the elderly and in patients with underlying cardiovascular disease:
Initiate Levothyroxine sodium capsules at less than the full replacement dose because of the increased risk of cardiac adverse reactions, including atrial fibrillation
Myxedema coma: Do not use oral thyroid hormone drug products to treat myxedema coma
Acute adrenal crisis in patients with concomitant adrenal insufficiency: Treat with replacement glucocorticoids prior to initiation of levothyroxine sodium capsules treatment
Prevention of hyperthyroidism or incomplete treatment of hypothyroidism: Proper dose titration and careful monitoring is critical to prevent the persistence of hypothyroidism or the development of hyperthyroidism
Worsening of diabetic control: Therapy in patients with diabetes mellitus may worsen glycemic control and result in increased antidiabetic agent or insulin requirements. Carefully monitor glycemic control after starting, changing, or discontinuing thyroid hormone therapy
Decreased bone mineral density associated with thyroid hormone over-replacement: Over-replacement can increase bone reabsorption and decrease bone mineral density. Give the lowest effective dose
Adverse Reactions
Common adverse reactions with levothyroxine therapy are primarily those of hyperthyroidism due to therapeutic overdosage. They include the following:
General: fatigue, increased appetite, weight loss, heat intolerance, fever, excessive sweating
Central Nervous System: headache, hyperactivity, nervousness, anxiety, irritability, emotional ability, insomnia
Musculoskeletal: tremors, muscle weakness
Cardiovascular: palpitations, tachycardia, arrythmias, increased pulse and blood pressure, heart failure, angina, myocardial infarction, cardiac arrest
Respiratory: dyspnea
Gastrointestinal (GI): diarrhea, vomiting, abdominal cramps, elevations in liver function tests
Dermatologic: hair loss, flushing
Endocrine: decreased bone mineral density
Reproductive: menstrual irregularities, impaired fertility
Adverse Reactions in Children
Pseudotumor cerebri and slipped capital femoral epiphysis have been reported in children receiving levothyroxine therapy. Overtreatment may result in craniosynostosis in infants and premature closure of the epiphyses in children with resultant compromised adult height. Seizures have been reported rarely with the institution of levothyroxine therapy.
Hypersensitivity Reactions
Hypersensitivity reactions to inactive ingredients (in this product or other levothyroxine products) have occurred in patients treated with thyroid hormone products. These include urticaria, pruritis, skin rash, flushing, angioedema, various GI symptoms (abdominal pain, nausea, vomiting and diarrhea), fever, arthralgia, serum sickness and wheezing. Hypersensitivity to levothyroxine itself is not known to occur.
Drug Interactions:
Many drugs and some foods can exert effects on thyroid hormone pharmacokinetics (e.g., absorption, synthesis, secretion, catabolism, protein binding, and target tissue response) and may alter the therapeutic response to Levothyroxine sodium capsules. Administer at least 4 hours before or after drugs that are known to interfere with absorption. See full prescribing information for drugs that affect thyroid hormone pharmacokinetics and metabolism.
To report SUSPECTED ADVERSE REACTIONS, contact Yaral Pharma Inc. at 1-866-218-9009, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. For Full Prescribing Information, including Boxed Warning, go to www.yaralpharma.com/levothyroxine-pi.



Wednesday Oct 08, 2025
Live from the FrameworkLTC Innovation Conference (Part 1) | FrameworkFocus™
Wednesday Oct 08, 2025
Wednesday Oct 08, 2025
In part one of our special three-part series, join host Todd Eury as he takes you inside the 2025 FrameworkLTC Innovation Conference. Recorded live on-site, this episode features conversations with long-term care (LTC) pharmacy leaders, partner exhibitors, and members of the SoftWriters team. Hear firsthand insights and success stories that highlight innovation, collaboration, and the future of LTC pharmacy.



Tuesday Oct 07, 2025
Tuesday Oct 07, 2025
In this episode of The Executive Dose, host Stephen Beckman, CEO of YARAL Pharma, sits down with Tom Napolitano, Senior Vice President and General Manager of Real Value Rx. With more than 30 years of experience across distribution, purchasing, and pharmaceutical operations, Tom brings unmatched perspective on how strategy, partnerships, and execution define success in the pharmacy supply chain.
Guest Spotlight – Tom Napolitano
Current Role: SVP & General Manager, Real Value Rx – overseeing nationwide sales, purchasing, and operations.
Previous Leadership: Chief Operating Officer at Praxis Med, driving national partnerships with retailers and suppliers.
Industry Roots: Over two decades at Cardinal Health in senior roles across purchasing, distribution, and pricing innovation.
Key Themes in This Episode
How distribution partnerships shape the economics and stability of the pharmacy industry.
The balance between generic and brand purchasing strategies for long-term growth.
The evolving role of technology and data in supply chain decision-making.
Lessons from Tom on drug shortages, preparation, and aligning with flexible organizations in drug wholesale.
Why collaboration between distributors, manufacturers, and pharmacies is critical to serving patients effectively.
Why Listen
This conversation provides rare insights into the strategic decisions that drive pharmacy distribution and supply chain resilience. Whether you’re a pharmacy executive, supplier, or healthcare innovator, Tom Napolitano’s perspective offers practical lessons on partnership, scale, and operational excellence.



Monday Oct 06, 2025
Acetaminophen in Pregnancy: Sorting Facts from Fears | MaternalRx
Monday Oct 06, 2025
Monday Oct 06, 2025
REFERENCES
1. Miller RV. Tylenol autism lawsuit. Lawsuit Information Center. September 21, 2025. Accessed September 25, 2025. https://www.lawsuit-information-center.com/tylenol-autism-lawsuit.html
2. Gerstein AS, Niederhelman EF. Harvard’s public health dean was paid $150,000 to testify Tylenol causes autism. The Harvard Crimson. September 24, 2025. Accessed September 25, 2025. https://www.thecrimson.com/article/2025/9/24/autism-dean-public-health/
3. Poll: Most Americans encounter health misinformation, and most aren’t sure whether it’s true or false. News Release. KFF. August 22, 2023. Accessed September 26, 2025. https://www.kff.org/covid-19/poll-most-americans-encounter-health-misinformation-and-most-arent-sure-whether-its-true-or-false/
4. Prada D, Ritz B, Bauer AZ, et al. Evaluation of the evidence on acetaminophen use and neurodevelopmental disorders using the Navigation Guide methodology. Environ Health. 2025 Aug 14;24(1):56. doi: 10.1186/s12940-025-01208-0.
5. Ahlqvist VH, Sjöqvist H, Dalman C, et al. Acetaminophen use during pregnancy and children’s risk of autism, ADHD, and intellectual disability. JAMA. 2024;331(14):1205–1214. doi:10.1001/jama.2024.3172
6. Alemany S, Avella-García C, Liew Z, et al. Prenatal and postnatal exposure to acetaminophen in relation to autism spectrum and attention-deficit and hyperactivity symptoms in childhood: meta-analysis in six European population-based cohorts. Eur J Epidemiol. 2021 Oct;36(10):993-1004. doi: 10.1007/s10654-021-00754-4.
7. Ji Y, Azuine RE, Zhang Y, et al. Association of cord plasma biomarkers of in utero acetaminophen exposure with risk of attention-deficit/hyperactivity disorder and autism spectrum disorder in childhood. JAMA Psychiatry. 2020;77(2):180–189. doi:10.1001/jamapsychiatry.2019.3259



Friday Oct 03, 2025
Celebrating the Launch of American Pharmacists Month 2025 | TWIRx
Friday Oct 03, 2025
Friday Oct 03, 2025
Celebrating the Launch of American Pharmacists Month 2025“Caring for our Communities”
This Week in Pharmacy (TWIRx)
Friday, October 3, 2025
Episode Overview
Today marks the kickoff of American Pharmacists Month 2025, a time to recognize the essential role pharmacists play across all healthcare settings. This special TWIRx episode spotlights leaders and innovators shaping pharmacy practice, technology, and patient care — and challenges the profession to embrace a 31-day journey of advocacy, community connection, and transformation.TWIRx NEWSFormer Rep. Tiahrt: Pharmacy Benefit Manager bill could shut down CVS in Kansas | Opinion Read more at:https://www.kansas.com/opinion/guest-commentary/article312355904.html#storylink=cpyNeronha lawsuit against CVS Caremark can help save my Middletown pharmacy: Guest Viewhttps://www.newportri.com/story/opinion/columns/guest/2025/10/03/neronha-lawsuit-against-cvs-can-help-save-middletown-pharmacy-guest-view/86471928007/
FDA Approves Lurbinectedin Combination Regimen in Extensive-Stage SCLC https://www.pharmacytimes.com/view/fda-approves-lurbinectedin-combination-regimen-in-extensive-stage-sclc
Building an Opioid Stewardship Program in Cancer Care: Pharmacist Roles, Challenges, and Patient Safety
https://www.pharmacytimes.com/view/building-an-opioid-stewardship-program-in-cancer-care-pharmacist-roles-challenges-and-patient-safety
Featured Guests
Dr. Jesse McCullough, PharmDFounder, Keystone Pharmacy InsightsIntroducing the American Pharmacists Month 31-Day Challenge, a call to action for pharmacists to engage, educate, and elevate their communities.
Bil SchmidtknechtPatient ProtectorSharing insights on patient advocacy, protecting access to care, and the pharmacist’s role in navigating today’s healthcare complexities.
Dr. Devin Bustin, MDChief Medical Officer, OvaryIt
Dr. Lissette Logan, PharmDCOO, OvaryItTogether, Dr. Bustin and Dr. Logan discuss innovative pharmacist-driven care models, treatment tracking, and platforms like PRISM designed to ensure pharmacists are recognized — and reimbursed — for their expertise.
Dr. Jill Kolesar, PharmDDean, College of Pharmacy, The University of IowaHighlighting the future of pharmacy education and how academia is preparing the next generation for expanded clinical and community roles.
Dr. Jason Lang, PharmDWellgisticsExploring the logistics and supply chain innovations that keep pharmacies agile in serving patient needs, especially as new therapies and technologies emerge.
WELLGISTICS News: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/wellgistics-health-nasdaq-wgrx-and-theracosbio-partner-to-expand-nati-1079815
SUBSCRIBE TO TWIRx HERE:
https://open.spotify.com/show/52NZjr9asE8fLrrbsMvBlQ
Celebrating the Launch of American Pharmacists Month 2025 | TWIRx

Pharmacy Podcast Network
With 40+ different podcast programs and over 50+ different co-hosts helping to develop audio content about different subjects in pharmacy, the PPN delivers a unique publication to all healthcare professionals with a specific focus on pharmacy.









